send link to app

Roche CIT


4.0 ( 5360 ratings )
Referência Medical
Developer: F. Hoffmann-La Roche
Livre

CIT (Cancer ImmunoTherapy) is an application developed by Roche. It contains update cancer immunotherapy scientific information. This platform is intended for the exclusive use by Healthcare Professionals in Taiwan.
It is designed to unsolicited provide scientific updated related to cancer immunotherapy and provide clinical supporting tool related to cancer immunotherapy treatment. It features personalized and interactive design to facilitate the scientific exchange.